Hepatitis D virus

A call to screening

Joseph Ahn, Robert G. Gish

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Hepatitis D virus causes an aggressive viral hepatitis with a virulent course of progression to cirrhosis and hepatic decompensation. It relies on hepatitis B coinfection for its pathogenesis and propagation. Hepatitis D virus had become the forgotten virus, with reduced public awareness, medical interest, and research support. Recently, there has been a resurgence of awareness and interest in hepatitis D, with improvements in diagnostic testing and establishment of international collaborative efforts to improve therapy. This article provides a framework to understand the impetus for increased screening as well as to identify key issues toward which collaborative efforts can be directed.

Original languageEnglish (US)
Pages (from-to)647-686
Number of pages40
JournalGastroenterology and Hepatology
Volume10
Issue number10
StatePublished - Oct 1 2014

Fingerprint

Hepatitis Delta Virus
Hepatitis D
Hepatitis B
Coinfection
Liver Cirrhosis
Hepatitis
Viruses
Therapeutics

Keywords

  • Cirrhosis
  • Hepatitis delta
  • Interferon
  • Pegylated interferon
  • Prenylation inhibitors

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Hepatitis D virus : A call to screening. / Ahn, Joseph; Gish, Robert G.

In: Gastroenterology and Hepatology, Vol. 10, No. 10, 01.10.2014, p. 647-686.

Research output: Contribution to journalArticle

Ahn, J & Gish, RG 2014, 'Hepatitis D virus: A call to screening', Gastroenterology and Hepatology, vol. 10, no. 10, pp. 647-686.
Ahn, Joseph ; Gish, Robert G. / Hepatitis D virus : A call to screening. In: Gastroenterology and Hepatology. 2014 ; Vol. 10, No. 10. pp. 647-686.
@article{28d958d70679489a8c26a74185f1dbc0,
title = "Hepatitis D virus: A call to screening",
abstract = "Hepatitis D virus causes an aggressive viral hepatitis with a virulent course of progression to cirrhosis and hepatic decompensation. It relies on hepatitis B coinfection for its pathogenesis and propagation. Hepatitis D virus had become the forgotten virus, with reduced public awareness, medical interest, and research support. Recently, there has been a resurgence of awareness and interest in hepatitis D, with improvements in diagnostic testing and establishment of international collaborative efforts to improve therapy. This article provides a framework to understand the impetus for increased screening as well as to identify key issues toward which collaborative efforts can be directed.",
keywords = "Cirrhosis, Hepatitis delta, Interferon, Pegylated interferon, Prenylation inhibitors",
author = "Joseph Ahn and Gish, {Robert G.}",
year = "2014",
month = "10",
day = "1",
language = "English (US)",
volume = "10",
pages = "647--686",
journal = "Gastroenterology and Hepatology",
issn = "1554-7914",
publisher = "Gastro-Hep Communications, Inc.",
number = "10",

}

TY - JOUR

T1 - Hepatitis D virus

T2 - A call to screening

AU - Ahn, Joseph

AU - Gish, Robert G.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Hepatitis D virus causes an aggressive viral hepatitis with a virulent course of progression to cirrhosis and hepatic decompensation. It relies on hepatitis B coinfection for its pathogenesis and propagation. Hepatitis D virus had become the forgotten virus, with reduced public awareness, medical interest, and research support. Recently, there has been a resurgence of awareness and interest in hepatitis D, with improvements in diagnostic testing and establishment of international collaborative efforts to improve therapy. This article provides a framework to understand the impetus for increased screening as well as to identify key issues toward which collaborative efforts can be directed.

AB - Hepatitis D virus causes an aggressive viral hepatitis with a virulent course of progression to cirrhosis and hepatic decompensation. It relies on hepatitis B coinfection for its pathogenesis and propagation. Hepatitis D virus had become the forgotten virus, with reduced public awareness, medical interest, and research support. Recently, there has been a resurgence of awareness and interest in hepatitis D, with improvements in diagnostic testing and establishment of international collaborative efforts to improve therapy. This article provides a framework to understand the impetus for increased screening as well as to identify key issues toward which collaborative efforts can be directed.

KW - Cirrhosis

KW - Hepatitis delta

KW - Interferon

KW - Pegylated interferon

KW - Prenylation inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84908364383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908364383&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 647

EP - 686

JO - Gastroenterology and Hepatology

JF - Gastroenterology and Hepatology

SN - 1554-7914

IS - 10

ER -